InVentiv Health Acquires Strategyx

  • June 21, 2007
InVentiv Health, Inc., New York, is acquiring Strategyx, LLC, a strategic consulting firm dedicated to the pharmaceutical and biotechnology industries. Financial terms of the transaction were not disclosed.

Strategyx is a Somerville, N.J.-based consulting firm focused on product strategy, market segment strategy and organization design. Its clients include U.S. and European pharma and biotechnology corporations including Allergan, Biogen Idec, Bristol-Myers Squibb, sanofi-aventis and Diachii Sankyo. It is organized into three practice areas--Product Strategy, Market Segment Strategy and Organization Design.

InVentiv Health provides commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its three core business segments: inVentiv Clinical, inVentiv Communications and inVentiv Commercial. inVentiv Health currently works with over 200 unique pharmaceutical, biotech and life sciences clients, including all top 20 global pharmaceutical companies.



Next story loading loading..